CompaniesAvenge Bio

Avenge Bio

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

14

By Phase

PHASE1/PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
NCT05538624
Hover over trial bars to see details

Recent Trials

NCT05538624Lead Sponsor
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
PHASE1/PHASE2Terminated
14 participants
Started: Dec 9, 2022 · Completed: Apr 10, 2024
Avenge Bio | Biotech Hunter | Biotech Hunter